山莨菪碱足三里穴位注射联合思密达口服治疗小儿轮状病毒性肠炎的临床疗效

Injecting Anisodamine at Zusanli Point plus Orally Administering Smecta for Treating Children＇s Rotaviral Enteronitis

为探讨山莨菪碱足三里穴位注射联合思密达口服治疗小儿轮状病毒性肠炎的临床疗效，将2011年6月至2013年6月我院儿科收治的120例轮状病毒性肠炎患儿随机分为观察组和对照组，各60例。对照组给予常规治疗（静脉滴注利巴韦林、补液），观察组在对照组治疗的基础上给予山莨菪碱足三里穴位注射和思密达口服，比较两组患儿的治疗总有效率、退热时间、止泻时间、住院时间及不良反应发生情况。结果显示，观察组总有效率（95．0％）明显高于对照组（81．7％），P〈0．05。观察组患儿退热时间、止泻时间、住院时间明显短于对照组，P〈0．05；两组均未发生明显不良反应。结果表明，在常规治疗基础上应用山莨菪碱足三里穴位注射联合思密达口服治疗小儿轮状病毒性肠炎安全可靠、疗效显著，且起效快，无不良反应，值得临床推广应用。

In order to investigate the clinical effect of injecting anisodamine at Zusanli point plus orally ad- ministering Smecta for treating children＇s rotaviral enteronitis（RE）, author＇s department divided 120 children with RE who admitted in this dept. from June,2011yr. to June,2013yr. randomly into observation group and control one, 60 cases for each; gave control group with routine therapy（intravenously injecting ribavirin, clysis）, added observation group with injecting anisodamine at Zusanli point plus orally administe- ring Smecta;then the total effective rate,the time for pyretolysis, the time for stopping diarrhea,the hospi- talization time,and adeverse reaction in both groups were compared each other. As results, the total effec- tive rate of observation group was significantly higher than that of control one（95.0% vs 81.7%, P〈0.05） ,and it＇s the time for pyretolysis,stopping diarrhea as well hospitalization were all significantly shor- ter than that of control group（ P 〈0.05） ;as to significant adverse reaction both groups did not occur. Re- sults show that on the basis of conventional treatment above-mentioned combination therapy for treating children＇s RE is safe and feasibile, and has significant therapeutic effect, fast onset, no adverse reaction, thus is worthy to be popularized clinically.